Last 12 months
Inside the activity.
2 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 14 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 2 | 4 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 07, 2024 Filed Feb 9, 2024 21:10 UTC |
McDermott William RDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 468 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000075 · wk-form4_1707513004.xml · nonDerivative · entry 3 McDermott William R · CIK 0001334944 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,534 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:10 UTC |
McDermott William RDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 4,739 | $790.39 | $3,745,658.21 |
DisclosureSEC source: 0001373715-24-000075 · wk-form4_1707513004.xml · nonDerivative · entry 2 McDermott William R · CIK 0001334944 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,066 F1 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:10 UTC |
McDermott William RDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 9,929 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000075 · wk-form4_1707513004.xml · nonDerivative · entry 1 McDermott William R · CIK 0001334944 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,805 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 111 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000076 · wk-form4_1707513031.xml · derivative · entry 6 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 445 Underlying: Common Stock · 111 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F5 · derivative.exercise_date: The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting occurring on May 7, 2021, and subject to the continued service of the Reporting Person on each vesting date. F5 · derivative.expiration_date: The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting occurring on May 7, 2021, and subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 2,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000076 · wk-form4_1707513031.xml · derivative · entry 5 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,358 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 8, 2021 under the Issuer's 2012 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2021 until December 31, 2021, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 24, 2022. F4 · derivative.exercise_date: 30% of the shares subject to the restricted stock units will vest on February 7, 2022, 15% of the shares subject to the restricted stock units will vest on each of August 7, 2022 and February 7, 2023, 20% of the shares subject to the restricted stock units will vest on August 7, 2023, and the final vest on February 7, 2024 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2021 to December 31, 2023, subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 8, 2021 under the Issuer's 2012 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2021 until December 31, 2021, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 24, 2022. F4 · derivative.expiration_date: 30% of the shares subject to the restricted stock units will vest on February 7, 2022, 15% of the shares subject to the restricted stock units will vest on each of August 7, 2022 and February 7, 2023, 20% of the shares subject to the restricted stock units will vest on August 7, 2023, and the final vest on February 7, 2024 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2021 to December 31, 2023, subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
Tax withholdingCommon Stock | 56 | $790.39 | $44,261.84 |
DisclosureSEC source: 0001373715-24-000076 · wk-form4_1707513031.xml · nonDerivative · entry 4 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,737 F1 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
Exercise / conversionCommon Stock | 111 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000076 · wk-form4_1707513031.xml · nonDerivative · entry 3 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
Tax withholdingCommon Stock | 990 | $790.39 | $782,486.10 |
DisclosureSEC source: 0001373715-24-000076 · wk-form4_1707513031.xml · nonDerivative · entry 2 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,682 F1 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
Exercise / conversionCommon Stock | 2,358 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000076 · wk-form4_1707513031.xml · nonDerivative · entry 1 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 176 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000077 · wk-form4_1707513060.xml · derivative · entry 6 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 702 Underlying: Common Stock · 176 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F6 · derivative.exercise_date: The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting occurring on May 7, 2021, and subject to the continued service of the Reporting Person on each vesting date. F6 · derivative.expiration_date: The restricted stock units vest as to 1/16th of the total shares quarterly, with the first vesting occurring on May 7, 2021, and subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000077 · wk-form4_1707513060.xml · derivative · entry 5 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F4 · derivative.exercise_date: 30% of the shares subject to the restricted stock units will vest on February 7, 2022, 15% of the shares subject to the restricted stock units will vest on each of August 7, 2022 and February 7, 2023, 20% of the shares subject to the restricted stock units will vest on August 7, 2023, and the final vest on February 7, 2024 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2021 to December 31, 2023, subject to the reporting person's continued service to the Issuer on each vesting date. F5 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 8, 2021 under the Issuer's 2012 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2021 until December 31, 2021, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 24, 2022. F4 · derivative.expiration_date: 30% of the shares subject to the restricted stock units will vest on February 7, 2022, 15% of the shares subject to the restricted stock units will vest on each of August 7, 2022 and February 7, 2023, 20% of the shares subject to the restricted stock units will vest on August 7, 2023, and the final vest on February 7, 2024 of 20% of the shares subject to the restricted stock units is subject to adjustment based on the Issuer's 3-year relative total stockholder return performance against the S&P 500 index for the period from January 1, 2021 to December 31, 2023, subject to the reporting person's continued service to the Issuer on each vesting date. F5 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based restricted stock units granted February 8, 2021 under the Issuer's 2012 Equity Incentive Plan. The performance period for the restricted stock units was January 1, 2021 until December 31, 2021, with achievement of the applicable performance criteria subject to determination by the Issuer's Compensation Committee. This determination was obtained on January 24, 2022. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
Tax withholdingCommon Stock | 88 | $790.39 | $69,554.32 |
DisclosureSEC source: 0001373715-24-000077 · wk-form4_1707513060.xml · nonDerivative · entry 4 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,957 F2 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
Exercise / conversionCommon Stock | 176 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000077 · wk-form4_1707513060.xml · nonDerivative · entry 3 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
Tax withholdingCommon Stock | 1,847 | $790.39 | $1,459,850.33 |
DisclosureSEC source: 0001373715-24-000077 · wk-form4_1707513060.xml · nonDerivative · entry 2 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,869 F2 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
Exercise / conversionCommon Stock | 3,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000077 · wk-form4_1707513060.xml · nonDerivative · entry 1 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 16 shares acquired under the Issuer's Employee Stock Purchase Plan on January 31, 2024. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:09 UTC |
Tzitzon NicholasChief Strat & Corp Affairs Ofc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,915 | $655.94 Strike: $655.94 | $2,568,005.10 |
DisclosureSEC source: 0001373715-24-000051 · wk-form4_1707426580.xml · derivative · entry 1 Tzitzon Nicholas · CIK 0001891538 · Chief Strat & Corp Affairs Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,745 Underlying: Common Stock · 3,915 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:10 UTC |
Canney Jacqueline PChief People Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,915 | $655.94 Strike: $655.94 | $2,568,005.10 |
DisclosureSEC source: 0001373715-24-000052 · wk-form4_1707426594.xml · derivative · entry 1 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,745 Underlying: Common Stock · 3,915 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 16:10 UTC |
ELMER RUSSELL SGeneral Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,915 | $655.94 Strike: $655.94 | $2,568,005.10 |
DisclosureSEC source: 0001373715-24-000053 · wk-form4_1707426618.xml · derivative · entry 1 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,745 Underlying: Common Stock · 3,915 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:10 UTC |
McDermott William RDirector · Chairman & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 69,384 | $697.76 Strike: $697.76 | $48,413,379.84 |
DisclosureSEC source: 0001373715-24-000054 · wk-form4_1707426642.xml · derivative · entry 1 McDermott William R · CIK 0001334944 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,152 Underlying: Common Stock · 69,384 shares Expires 2031-10-29 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on October 29, 2021, a Performance Stock Option (PSO) was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) the achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is either Chief Executive Officer or Executive Chairman of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on October 29, 2021, a Performance Stock Option (PSO) was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) the achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is either Chief Executive Officer or Executive Chairman of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:11 UTC |
Desai Chirantan JitendraPresident & COO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,663 | $655.94 Strike: $655.94 | $10,273,988.22 |
DisclosureSEC source: 0001373715-24-000055 · wk-form4_1707426663.xml · derivative · entry 1 Desai Chirantan Jitendra · CIK 0001661430 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,989 Underlying: Common Stock · 15,663 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:11 UTC |
Smith Paul JohnChief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,831 | $655.94 Strike: $655.94 | $5,136,666.14 |
DisclosureSEC source: 0001373715-24-000057 · wk-form4_1707426689.xml · derivative · entry 1 Smith Paul John · CIK 0001909194 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,493 Underlying: Common Stock · 7,831 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:11 UTC |
Mastantuono GinaChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 7,831 | $655.94 Strike: $655.94 | $5,136,666.14 |
DisclosureSEC source: 0001373715-24-000056 · wk-form4_1707426677.xml · derivative · entry 1 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,493 Underlying: Common Stock · 7,831 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 06, 2024 Filed Feb 8, 2024 21:11 UTC |
Bedi ChristopherChief Digital Information Ofc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 3,915 | $655.94 Strike: $655.94 | $2,568,005.10 |
DisclosureSEC source: 0001373715-24-000058 · wk-form4_1707426703.xml · derivative · entry 1 Bedi Christopher · CIK 0001908850 · Chief Digital Information Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,745 Underlying: Common Stock · 3,915 shares Expires 2031-12-13 F1 · derivative.exercise_date: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. F1 · balance_after: As the Issuer has previously disclosed, on December 13, 2021, a Performance Stock Option ("PSO") was granted to the Reporting Person. The Issuer also disclosed that there are eight separate tranches to the PSO and any tranche may vest only if both subscription revenue and stock price performance metrics are met, in addition to service requirements. The performance period ends September 30, 2026. On February 6, 2024, the Issuer's Compensation Committee certified achievement of the subscription revenue metric for Tranche Three of the PSO. Despite having met this performance metric, the shares for Tranche Three have not yet vested. They may vest, if at all, only if: (i) achievement of the applicable stock price metric is certified; and (ii) the Reporting Person is an employee of the Issuer on such vesting date. Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 00:57 UTC |
Bedi ChristopherChief Digital Information Ofc
|
SaleCommon Stock | 650 | $780.20 | $507,130.00 |
DisclosureSEC source: 0001373715-24-000034 · wk-form4_1707267454.xml · nonDerivative · entry 2 Bedi Christopher · CIK 0001908850 · Chief Digital Information Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,592 Read SEC document |
| February 02, 2024 Filed Feb 7, 2024 00:57 UTC |
Bedi ChristopherChief Digital Information Ofc
|
SaleCommon Stock | 500 | $785.00 | $392,500.00 |
DisclosureSEC source: 0001373715-24-000034 · wk-form4_1707267454.xml · nonDerivative · entry 1 Bedi Christopher · CIK 0001908850 · Chief Digital Information Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,242 F1 · balance_after: Includes 30 shares acquired under the Issuer's Employee Stock Purchase Plan on January 31, 2024. Read SEC document |
| January 30, 2024 Filed Jan 31, 2024 22:04 UTC |
Smith Paul JohnChief Commercial Officer
|
SaleCommon Stock | 1,795 | $781.06 | $1,402,004.50 |
DisclosureSEC source: 0001628280-24-002758 · wk-form4_1706738667.xml · nonDerivative · entry 1 Smith Paul John · CIK 0001909194 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $781.011 to $781.190 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 22:01 UTC |
Canney Jacqueline PChief People Officer
|
SaleCommon Stock | 837 | $776.61 | $650,020.06 |
DisclosureSEC source: 0001628280-24-002755 · wk-form4_1706738453.xml · nonDerivative · entry 1 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 994 F1 · price: Represents the weighted average sales price per share. The shares sold at prices ranging from $776.378 to $776.670 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:35 UTC |
Bedi ChristopherChief Digital Information Ofc
|
GrantRestricted Stock Units · Derivative | 12,552 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000019 · wk-form4_1706139301.xml · derivative · entry 2 Bedi Christopher · CIK 0001908850 · Chief Digital Information Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,552 Underlying: Common Stock · 12,552 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:35 UTC |
Bedi ChristopherChief Digital Information Ofc
|
GrantRestricted Stock Units · Derivative | 39 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000019 · wk-form4_1706139301.xml · derivative · entry 1 Bedi Christopher · CIK 0001908850 · Chief Digital Information Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,236 Underlying: Common Stock · 39 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:35 UTC |
Desai Chirantan JitendraPresident & COO
|
GrantRestricted Stock Units · Derivative | 34,758 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000020 · wk-form4_1706139313.xml · derivative · entry 2 Desai Chirantan Jitendra · CIK 0001661430 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,758 Underlying: Common Stock · 34,758 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:35 UTC |
Desai Chirantan JitendraPresident & COO
|
GrantRestricted Stock Units · Derivative | 107 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000020 · wk-form4_1706139313.xml · derivative · entry 1 Desai Chirantan Jitendra · CIK 0001661430 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,208 Underlying: Common Stock · 107 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 18:35 UTC |
ELMER RUSSELL SGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 12,359 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000021 · wk-form4_1706139326.xml · derivative · entry 2 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,359 Underlying: Common Stock · 12,359 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 18:35 UTC |
ELMER RUSSELL SGeneral Counsel
|
GrantRestricted Stock Units · Derivative | 41 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000021 · wk-form4_1706139326.xml · derivative · entry 1 ELMER RUSSELL S · CIK 0001197952 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,358 Underlying: Common Stock · 41 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 18:35 UTC |
McBride Kevin ThomasPrincipal Accounting Officer
|
GrantRestricted Stock Units · Derivative | 3,284 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000022 · wk-form4_1706139342.xml · derivative · entry 1 McBride Kevin Thomas · CIK 0001723374 · Principal Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,284 Underlying: Common Stock · 3,284 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F2 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
Smith Paul JohnChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 27,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000023 · wk-form4_1706139357.xml · derivative · entry 2 Smith Paul John · CIK 0001909194 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,034 Underlying: Common Stock · 27,034 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
Smith Paul JohnChief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000023 · wk-form4_1706139357.xml · derivative · entry 1 Smith Paul John · CIK 0001909194 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 862 Underlying: Common Stock · 15 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 17, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 17, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
McDermott William RDirector · Chairman & CEO
|
GrantRestricted Stock Units · Derivative | 57,930 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000024 · wk-form4_1706139371.xml · derivative · entry 2 McDermott William R · CIK 0001334944 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,930 Underlying: Common Stock · 57,930 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
McDermott William RDirector · Chairman & CEO
|
GrantRestricted Stock Units · Derivative | 171 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000024 · wk-form4_1706139371.xml · derivative · entry 1 McDermott William R · CIK 0001334944 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,929 Underlying: Common Stock · 171 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
Mastantuono GinaChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 22,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000025 · wk-form4_1706139386.xml · derivative · entry 2 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,207 Underlying: Common Stock · 22,207 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
Mastantuono GinaChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 65 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000025 · wk-form4_1706139386.xml · derivative · entry 1 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,725 Underlying: Common Stock · 65 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
Tzitzon NicholasChief Strat & Corp Affairs Ofc
|
GrantRestricted Stock Units · Derivative | 11,587 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000026 · wk-form4_1706139401.xml · derivative · entry 2 Tzitzon Nicholas · CIK 0001891538 · Chief Strat & Corp Affairs Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,587 Underlying: Common Stock · 11,587 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:36 UTC |
Tzitzon NicholasChief Strat & Corp Affairs Ofc
|
GrantRestricted Stock Units · Derivative | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000026 · wk-form4_1706139401.xml · derivative · entry 1 Tzitzon Nicholas · CIK 0001891538 · Chief Strat & Corp Affairs Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493 Underlying: Common Stock · 26 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted February 8, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:37 UTC |
Canney Jacqueline PChief People Officer
|
GrantRestricted Stock Units · Derivative | 13,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000027 · wk-form4_1706139415.xml · derivative · entry 2 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,518 Underlying: Common Stock · 13,518 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. F3 · derivative.expiration_date: Acquired upon achievement of certain performance criteria pursuant to the performance-based RSUs granted February 15, 2023, as determined by the Compensation Committee on January 22, 2024. Shares subject to the RSUs will vest as follows: 30% on February 17, 2024, 15% on each of August 17, 2024 and February 17, 2025, 20% on August 17, 2025, and 20% on February 17, 2026, with such final vesting subject to adjustment based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2025. Such vestings are subject to the reporting person's continued service to the Issuer on each vesting date. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 23:37 UTC |
Canney Jacqueline PChief People Officer
|
GrantRestricted Stock Units · Derivative | 30 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000027 · wk-form4_1706139415.xml · derivative · entry 1 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,719 Underlying: Common Stock · 30 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F2 · derivative.exercise_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted August 16, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. F2 · derivative.expiration_date: Additional shares scheduled to vest on February 7, 2024, pursuant to the terms of the performance-based restricted stock units ("RSUs") granted August 16, 2021, based on the Issuer's total shareholder return relative to the S&P 500 for the three years ended December 31, 2023, as determined by the Compensation Committee on January 22, 2024. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:13 UTC |
Canney Jacqueline PChief People Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 724 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000004 · wk-form4_1705525972.xml · derivative · entry 3 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,343 Underlying: Common Stock · 724 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest as to one-fourth (1/4th) of the total shares on July 15, 2022 and thereafter shall vest in equal quarterly installments over the next three (3) years, and subject to the continued service of the Reporting Person on each vesting date. F3 · derivative.expiration_date: The restricted stock units vest as to one-fourth (1/4th) of the total shares on July 15, 2022 and thereafter shall vest in equal quarterly installments over the next three (3) years, and subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:13 UTC |
Canney Jacqueline PChief People Officer
|
Tax withholdingCommon Stock | 273 | $729.18 | $199,066.14 |
DisclosureSEC source: 0001373715-24-000004 · wk-form4_1705525972.xml · nonDerivative · entry 2 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,831 F1 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:13 UTC |
Canney Jacqueline PChief People Officer
|
Exercise / conversionCommon Stock | 724 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000004 · wk-form4_1705525972.xml · nonDerivative · entry 1 Canney Jacqueline P · CIK 0001649609 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,104 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 22:24 UTC |
Mastantuono GinaChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000002 · wk-form4_1704925464.xml · derivative · entry 3 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock. F3 · derivative.exercise_date: The restricted stock units vest as to one-fourth (1/4th) of the total shares on January 8, 2021 and thereafter shall vest in equal quarterly installments over the next three (3) years, and subject to the continued service of the Reporting Person on each vesting date. F3 · derivative.expiration_date: The restricted stock units vest as to one-fourth (1/4th) of the total shares on January 8, 2021 and thereafter shall vest in equal quarterly installments over the next three (3) years, and subject to the continued service of the Reporting Person on each vesting date. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 22:24 UTC |
Mastantuono GinaChief Financial Officer
|
Tax withholdingCommon Stock | 560 | $696.26 | $389,905.60 |
DisclosureSEC source: 0001373715-24-000002 · wk-form4_1704925464.xml · nonDerivative · entry 2 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,975 F1 · shares: Represents shares relinquished by the Reporting Person in exchange for the Issuer's payment of federal and state tax withholding obligations of the Reporting Person resulting from the vesting of RSUs, in accordance with Rule 16b-3. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 22:24 UTC |
Mastantuono GinaChief Financial Officer
|
Exercise / conversionCommon Stock | 1,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001373715-24-000002 · wk-form4_1704925464.xml · nonDerivative · entry 1 Mastantuono Gina · CIK 0001465391 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.